Aspects of Breast-conserving Surgery
Prospective Study of Cosmetic Outcome and Quality of Life for Women Undergoing Breast Cancer Surgery
1 other identifier
observational
351
1 country
1
Brief Summary
Prospective study of cosmetic outcome and quality of life for women undergoing breast cancer surgery using patient a reported outcome measure (BREAST-Q) and a computer program validated to assess cosmetic outcomes after breast cancer surgery (BCCT.core) at baseline and on 1-year follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 9, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedNovember 21, 2022
November 1, 2022
3 years
January 9, 2020
November 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of life
Breast-Q questionnaire to evaluate quality of life and satisfaction with outcome for the patient.Score 0-100, higher score indicates a better outcome. There is also an additional QoL questionnaire at 1-year follow up (EORTC QLQ-C30 and QLQ-BR23).
Change from baseline (time of diagnosis) to 1-year follow-up
Cosmetic outcome
BCCT.core (breast cancer conservation treatment. cosmetic results) program, together with both surgeon's and patient's score to evaluate cosmetic outcome. BCCT.core scores from 1 to 4. 4 is the worse cosmetic outcome. Patients and surgeon will score from 1-10. Higher score indicates a better cosmetic outcome.
Change from baseline (time of diagnosis) to 1-year follow-up
Eligibility Criteria
All women who are diagnosed with breast cancer in Central Hospital of Kristianstad
You may qualify if:
- Women with breast cancer diagnosed in Central Hospital of Kristianstad from 1/1 2019
You may not qualify if:
- Patients who lack the ability to read and write Swedish
- Patients that are not able to understand the information given
- Palliative care patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
- Region Skanecollaborator
Study Sites (1)
Central Hospital of Kristianstad
Kristianstad, Skåne County, 29133, Sweden
Related Publications (1)
Gulis K, Ellbrant J, Bendahl PO, Svensjo T, Ryden L. Health-related quality of life by type of breast surgery in women with primary breast cancer: prospective longitudinal cohort study. BJS Open. 2024 May 8;8(3):zrae042. doi: 10.1093/bjsopen/zrae042.
PMID: 38829692DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Rydén, Prof
Lund University
- PRINCIPAL INVESTIGATOR
Tor Svensjö, PhD
Region Skåne
- PRINCIPAL INVESTIGATOR
Kim Gulis, MD
Region Skåne / Lund University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2020
First Posted
January 13, 2020
Study Start
January 1, 2019
Primary Completion
December 31, 2021
Study Completion
June 30, 2022
Last Updated
November 21, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share